Vivani Medical Inc has a consensus price target of $7 based on the ratings of 1 analysts. The high is $7 issued by ThinkEquity on December 5, 2022. The low is $7 issued by ThinkEquity on December 5, 2022. The 1 most-recent analyst ratings were released by ThinkEquity on December 5, 2022, respectively. With an average price target of $7 between ThinkEquity, there's an implied 471.43% upside for Vivani Medical Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Vivani Medical (NASDAQ:VANI) was reported by ThinkEquity on December 5, 2022. The analyst firm set a price target for $7.00 expecting VANI to rise to within 12 months (a possible 471.43% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Vivani Medical (NASDAQ:VANI) was provided by ThinkEquity, and Vivani Medical initiated their buy rating.
There is no last upgrade for Vivani Medical
There is no last downgrade for Vivani Medical.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vivani Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vivani Medical was filed on December 5, 2022 so you should expect the next rating to be made available sometime around December 5, 2023.
While ratings are subjective and will change, the latest Vivani Medical (VANI) rating was a initiated with a price target of $0.00 to $7.00. The current price Vivani Medical (VANI) is trading at is $1.23, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.